Steven W. Bass, PhD

Steven W. Bass, PhD

President
Bass BioPharm Consulting Group LLC
stevenbassbbcg@me.com
P.
610-306-0463

 

Dr. Bass is President of Bass BioPharm Consulting Group, LLC, and serves as Vice President, Talent Acquisition for Ruderfer and Associates, an executive biopharmaceutical search firm.

Dr. Bass recently retired from Bristol-Myers Squibb as Group Director, Global Labeling and Promotion Compliance. He and his department were responsible for developing global labeling for products in early and full clinical development, managing labeling changes to Marketed Products, and coordinating all changes to the Company Core Data Sheet.

During his professional career, Dr. Bass has had senior regulatory and clinical positions with a number of companies, including Pfizer Pharmaceuticals, Clinical Resources Inc, Fujisawa and Fujisawa SmithKline Corporation, Wyeth-Ayerst, and Eastman Pharmaceuticals.

Dr. Bass has chaired and presented at DIA, RAPS, and PhRMA on Electronic NDAs, the FDA Prescription Drug User Fee Act, Global Dossiers, and the Format and Content of the US Package Insert.  He currently serves as the chair of the Labeling Working Group of the Drug Information Association (DIA) Regulatory Affairs SIAC; he is on the faculty of the Pharmaceutical Education & Research Institute (PERI); and is Director for the Workshop entitled, “Regulatory Review of US Prescription Drug Labeling.” He has served on the Editorial Board of the DIA and is currently on the Board of Directors and past President of the Alumni Association of Thomas Jefferson University: Jefferson Graduate School of Biomedical Sciences. Steve has also served as an Adjunct Professor in Quality Assurance and taught the course on Global Labeling in the Temple University RA/QA program. He was the Recipient of the FDA “Commissioner’s Special Citation” as a member of the CANDA Guidance Manual Task Force, and received the FDA “Commissioner’s Special Citation” for the creation of the “SPL Implementation Guide for FDA Content of Labeling Submission.”

Steve received his bachelor of science degree in pharmacy from the Philadelphia College of Pharmacy and Science and his doctoral degree in pharmacology/toxicology from Thomas Jefferson University College of Graduate Studies.  He did a postdoctoral fellowship in cardiovascular/pulmonary pharmacology at the University of Pennsylvania.  He has taken additional postgraduate training in medical microbiology at Temple University Medical School.